In the interplay between CSCs and TAMs, a putative role for the signal transducer and activator of transcription 3 (STAT3) pathway has been demonstrated in breast cancer models via a novel paracrine EGFR/Stat3/Sox-2 axis [32]. Here, STAT3 is linked to breast carcinoma.